J.Henderson H.BioTech.F.H2/ LU1897414485 /
| NAV6/9/2023 | Chg.+0.0300 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 21.0800USD | +0.14% | reinvestment | Equity Worldwide | Janus Henderson Inv. ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | 16.00 | 5.13 | -0.35 | -3.02 | -4.68 | 5.20 | -2.10 | -1.96 | -4.67 | 7.50 | 11.35 | 4.43 | +35.14% |
| 2020 | -2.56 | -5.91 | -4.62 | 15.46 | 6.58 | 9.74 | 1.76 | 2.33 | 2.54 | 1.08 | 14.63 | 11.23 | +62.48% |
| 2021 | 0.64 | 1.32 | -4.59 | 1.72 | -3.68 | 2.84 | -4.62 | 9.27 | -2.27 | 0.84 | -8.41 | 2.24 | -5.71% |
| 2022 | -18.75 | -1.03 | 0.58 | -9.49 | -5.28 | 2.18 | 5.01 | 6.53 | 3.82 | 8.38 | 4.63 | 3.81 | -3.13% |
| 2023 | 2.10 | -3.12 | 2.02 | 4.54 | 3.32 | 4.25 | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 19.61% | 19.29% | 23.32% | 25.09% | -% |
| Sharpe ratio | 1.58 | 1.98 | 2.38 | 0.46 | - |
| Best month | +4.54% | +4.54% | +8.38% | +14.63% | +16.00% |
| Worst month | -3.12% | -3.12% | -3.12% | -18.75% | -18.75% |
| Maximum loss | -8.22% | -8.22% | -8.37% | -46.30% | - |
| Outperformance | +1.27% | - | +19.74% | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| J.Henderson H.BioTech.F.IU2 | reinvestment | 21.2200 | +59.79% | +53.55% | |
| J.Henderson H.BioTech.F.A2 | reinvestment | 20.9500 | +59.07% | +52.70% | |
| J.Henderson H.BioTech.F.H2 | reinvestment | 21.0800 | +58.85% | +52.42% |
Performance
| YTD | +13.64% | ||
|---|---|---|---|
| 6 Months | +18.96% | ||
| 1 Year | +58.85% | ||
| 3 Years | +52.42% | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | +110.80% | ||
| Year | |||
| 2022 | -3.13% | ||
| 2021 | -5.71% | ||
| 2020 | +62.48% | ||
| 2019 | +35.14% | ||